GSTP1 CpG island hypermethylation as a molecular marker in the carcinogenesis of prostate cancer;Die GSTP1-CpG-insel-hypermethylierung als molekularer marker des prostatakarzinoms

Urologe - Ausgabe A

Volumn 43, Issue 5, 2004, Pages 573-579

  Bastian, P J ^a   Nakayama, M ^a   De Marzo, A M ^a,b   Nelson, W G ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

CpG island; DNA methylation; Glutathione S transferase; Prostate cancer

Indexed keywords

GLUTATHIONE TRANSFERASE; MOLECULAR MARKER; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BLOOD; BODY FLUID; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SCREENING; CARCINOGENESIS; CPG ISLAND; DNA METHYLATION; EUROPE; HISTOLOGY; HUMAN; LYMPH NODE; NORTH AMERICA; PROGNOSIS; PROSTATE CANCER; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROSTATE SECRETION; SPERM; URINE LEVEL;

ACYLTRANSFERASES; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MALE; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 2942596061     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-004-0540-7     Document Type: Article

References (54)

1. Adler V, Yin Z, Tew KD, Ronai Z (1999) Role of redox potential and reactive oxygen species in stress signaling. Oncogene 18: 6104-6111
2. Attwood JT, Yung RL, Richardson BC (2002) DNA methylation and the regulation of gene transcription. Cell Mol Life Sci 59: 241-257
3. Bartsch G, Horninger W, Klocker H et al. (2001) Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria. Urology 58: 417-424
4. Bastian PJ, Ellinger J, Wernert N, Wellmann A, Müller SC, Rücker AA von (2004) GSTP1 Hypermethylation as a molecular marker in the diagnosis of prostatic cancer: Is there a correlation with clinical stage, gleason grade, P5A value or age? Onkologie (einger. zur Publikation)
5. Brooks JD, Weinstein M, Lin X et al. (1998) CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev 7: 531-536
6. Cairns P, Esteller M, Herman JG, Schoenberg M, Jeronimo C, Sanchez-Cespedes M, Chow NH, Grasso M, Wu L, Westra WB, Sidransky D. (2001) Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. Clin Cancer Res 7: 2727-2730
7. Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB (1999) Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 21: 103-107
8. Catalona WJ, Beiser JA, Smith DS (1997) Serum free prostate specific antigen and prostate specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies. J Urol 158: 2162-2167
9. Cavaliere A, Bufalari A, Vitali R. (1987) 5-Azacytidine carcinogenesis in BALB/c mice. Cancer Lett 37: 51-58
10. Chon CH, Lai FC, McNeal JE, Presti JC Jr. (2002) Use of extended systematic sampling in patients with a prior negative prostate needle biopsy. J Urol 167: 2457-2460
11. Chu DC, Chuang CK, Fu JB et al. (2002) The use of real-time quantitative polymerase chain reaction to detect hypermethylation of the CpG islands in the promoter region flanking the GSTP1 gene to diagnose prostate carcinoma. J Urol 167: 1854-1858
12. Dahl C, Guldberg P (2003) DNA methylation analysis techniques. Biogerontology 4: 233-250
13. De Marzo AM, Marchi VL, Epstein JI, Nelson WG (1999) Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 155: 1985-1992
14. Denda A, Mori Y, Yokose Y et al. (1985) 4-Hydroxyaminoquinoline 1-oxide metabolism and DNA adducts in the early stage of tumorigenesis in rats: comparison of target organ pancreas with non-target organ liver. Chem Biol Interact 56: 125-143
15. De Weese TL, Shipman JM, Larrier NA et al. (1998) Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally to oxidative stress inflicted by low-level radiation. Proc Natl Acad Sci USA 95: 11915-11920
16. Esteller M, Corn PG, Urena JM et al. (1998) Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia. Cancer Res 58: 4515-4518
17. Esteller M, Corn PG, Baylin SB, Herman JG (2001) A gene hypermethylation profile of human cancer. Cancer Res 61: 3225-3229
18. Frommer M, McDonald LE, Millar DS et al.. (1992) A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 89: 1827-1831
19. Gattoni-Celli S, Hsiao WL, Lambert M, Kirschmeier P, Weinstein IB (1985) Genetic targets in multistage carcinogenesis. Carcinog Compr Surv 9: 29-40
20. Goessl C, Krause H, Muller M et al. (2000) Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids. Cancer Res 60: 5941-5945
21. Goessl C, Muller M, Heicappell R et al. (2001) DNA-based detection of prostate cancer in urine after prostatic massage. Urology 58: 335-338
22. Goessl C, Muller M, Heicappell R, Krause H, Miller K (2001) DNA-based detection of prostate cancer in blood, urine, and ejaculates. Ann N Y Acad Sci 945: 51-58
23. Gonzalgo ML, Pavlovich CP, Lee SM, Nelson WG (2003) Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens. Clin Cancer Res 9: 2673-2677
24. Hankey BF, Ries LA, Edwards BK (1999) The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev 8: 1117-1121
25. Harden SV, Guo Z, Epstein JI, Sidransky D (2003) Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma. J Urol 169: 1138-1142
26. Henderson CJ, Wolf CR, Kitteringham N et al. (2000) Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase Pi. Proc Natl Acad Sci USA 97: 12741-12745
27. Herman JG, Baylin SB (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349: 2042-2054
28. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826
29. Hsiao WL, Gattoni-Celli S, Weinstein IB (1985) Effects of 5-azacytidine on the progressive nature of cell transformation. Mol Cell Biol 5: 1800-1803
30. Jackson-Grusby L, Laird PW, Magge SN, Moeller BJ, Jaenisch R (1997) Mutagenicity of 5-aza-2′-deoxycytidine is mediated by the mammalian DNA methyltransferase. Proc Natl Acad Sci USA 94: 4681-4685
31. Jemal A, Murray T, Samuels A et al. (2003) Cancer statistics, 2003. CA Cancer J Clin 53: 5-26
32. Jones PA (2002) DNA methylation and cancer. Oncogene 21: 5358-5360
33. Jones PA, Taylor SM (1980) Cellular differentiation, cytidine analogs and DNA methylation. Cell 20: 85-93
34. Jeronimo C, Usadel H, Henrique R et al. (2001) Quantitation ofGSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. J Natl Cancer Inst 93: 1747-1752
35. Jeronimo C, Usadel H, Henrique R et al. (2002) Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer. Urology 60: 1131-1135
36. Lee WH, Morton RA, Epstein JI et al. (1994) Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. Proc Natl Acad Sci USA 91: 11733-11737
37. Lee WH, Isaacs WB, Bova GS, Nelson WG (1997) CG island methylation changes near the GSTP1 gene in prostatic carcinoma cells detected using the polymerase chain reaction: a new prostate cancer biomarker. Cancer Epidemiol Biomarkers Prev 6: 443-450
38. Lin X, Tascilar M, Lee WH et al. (2001) GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. Am J Pathol 159: 1815-1826
39. Kallakury BV, Sheehan CE, Winn-Deen E et al. (2001) Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas. Cancer 92: 2786-2795
40. Kollermann J, Muller M, Goessl C et al. (2003) Methylation-specific PCR for DNA-based detection of occult tumor cells in lymph nodes of prostate cancer patients. Eur Urol 44: 533-538
41. Maruyama R, Toyooka S, Toyooka KO et al. (2002) Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. Clin Cancer Res 8: 514-519
42. Millar DS, Ow KK, Paul CL, Russell PJ, Molloy PL, Clark SJ. (1999) Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer. Oncogene 18: 1313-1324
43. Nakayama M, Bennett CJ, Hicks JL et al. (2003) Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection. Am J Pathol 163: 923-933
44. Nelson CP, Kidd LC, Sauvageot J et al. (2001) Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1. Cancer Res 61: 103-109
45. Nelson WG, De Marzo AM, Isaacs WB (2003) Prostate cancer. N Engl J Med 349: 366-381
46. Nuovo GJ, Plaia TW, Belinsky SA, Baylin SB, Herman JG (1999) In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc Natl Acad Sci USA 96: 12754-12759
47. Ruscoe JE, Rosario LA, Wang T et al. (2001) Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways. J Pharmacol Exp Ther 298: 339-345
48. Santini V, Kantarjian HM, Issa JR (2001) Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann Intern Med 134: 573-586
49. Santourlidis S, Florl A, Ackermann R, Wirtz HC, Schulz WA (1999) High frequency of alterations in DNA methylation in adenocarcinoma of the prostate. Prostate 39: 166-174
50. Shirai T, Sano M, Tamano S et al. (1997) The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods. Cancer Res 57: 195-198
51. Stuart GR, Holcroft J, de Boer JG,Glickman BW (2000) Prostate mutations in rats induced by the suspected human carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Cancer Res 60: 266-268
52. Suh CI, Shanafelt T, May DJ et al.(2000) Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer. Mol Cell Probes 14: 211-217
53. Suzuki H, Gabrielson E, Chen W et al. (2002) Agenomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 31: 141-149
54. Tchou JC, Lin X, Freije D et al. (2000) GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas. Int J Oncol 16: 663-676